These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20408737)

  • 21. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis.
    Boonyaleepun S; Boonyaleepun C; Schlactus JL
    Asian Pac J Allergy Immunol; 1999 Mar; 17(1):59-62. PubMed ID: 10403010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of ulcerative and diabeticorum necrobiosis lipoidica with intravenous immunoglobulin in a patient with common variable immunodeficiency.
    Barouti N; Cao AQ; Ferrara D; Prins C
    JAMA Dermatol; 2013 Jul; 149(7):879-81. PubMed ID: 23864091
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of common variable immunodeficiency syndrome associated with Takayasu arteritis.
    Jerschow E; De Vos GS; Hudes G; Rubinstein A; Lipsitz EC; Rosenstreich D
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):196-9. PubMed ID: 17304891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary complications of common variable immunodeficiency.
    Busse PJ; Farzan S; Cunningham-Rundles C
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):1-8; quiz 8-11, 43. PubMed ID: 17225714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases.
    Ersoy F; Tezcan I; Sanal O
    Turk J Pediatr; 1992; 34(4):203-9. PubMed ID: 1306339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wegener's granulomatosis associated with common variable immunodeficiency.
    Delèvaux I; André M; Aumaître O
    J Rheumatol; 2002 Jul; 29(7):1577-8. PubMed ID: 12136927
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2012 Jun; 147(3):259-67. PubMed ID: 22648327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
    Shapiro RS
    Immunotherapy; 2012 Dec; 4(12):1835-9. PubMed ID: 23240751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The simultaneous presentation of sarcoidosis and common variable immune deficiency.
    Ameratunga R; Becroft DM; Hunter W
    Pathology; 2000 Nov; 32(4):280-2. PubMed ID: 11186425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrotizing ulcerative periodontitis associated with severe congenital immunodeficiency in a prepubescent subject: clinical findings and response to intravenous immunoglobulin treatment.
    Batista EL; Novaes AB; Calvano LM; do Prado EA; Goudouris ES; Batista FC
    J Clin Periodontol; 1999 Aug; 26(8):499-504. PubMed ID: 10450809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute renal dysfunction caused by nonsucrose intravenous immunoglobulin in common variable immunodeficiency.
    Kim AS; Broide DH
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):231-233. PubMed ID: 28024991
    [No Abstract]   [Full Text] [Related]  

  • 40. [Common variable immunodeficiency (CVID) -- variable immunodeficiency syndrome].
    Suter-Meyer E; Nigg C; Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Jan; 96(1-2):3-10; quiz 11-2. PubMed ID: 17256555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.